Allergic Bronchopulmonary Aspergillosis in Children with Asthma: A Multicenter Study on Clinical Manifestations and Management across Three Hospitals in India
Background: Allergic bronchopulmonary aspergillosis (ABPA) is an immunological disorder caused by hypersensitivity to Aspergillus fumigatus, frequently complicating asthma in children. However, limited data are available regarding its clinical profile and management in pediatric populations in India.
Objective: This study investigates the clinical features, diagnostic findings, and therapeutic outcomes of ABPA in children with asthma across three tertiary care centers in India.
Methods: A prospective, multicenter observational study was conducted between January 2020 and December 2023, including children aged 6–18 years with asthma and ABPA. Data on clinical presentation, laboratory parameters, imaging findings, and treatment responses were collected and analyzed.
Results: Of 120 enrolled children, uncontrolled asthma was present in 65%, central bronchiectasis in 55%, and recurrent pulmonary infiltrates in 70%. Elevated total IgE levels (>1,000 IU/mL) and positive Aspergillus fumigatus-specific IgE were observed in all cases. Treatment with corticosteroids and itraconazole led to symptom resolution in 78%, although relapses occurred in 22%.
Conclusion: This study emphasizes the importance of early diagnosis and standardized treatment of ABPA in asthmatic children to prevent long-term pulmonary complications.